Finance

Alexandra Hospital develops world's novel A.I. algorithm (with international patent) that enhances accuracy and efficiency of robotic total knee replacement

Newspoints: An A.I. algorithm for robotic total knee replacement (rTKR) has secured an international Patent Cooperation Treaty (PCT) patent[1],that protects this algorithm for robotic total knee repl

02-13 Alexandra Hospital (AH)

Rees Ward Transitions into Key Leadership Role at Bridgewest Group as Operating Partner and General Manager, New Zealand

MIAMI and AUCKLAND,New Zealand,Feb. 12,2025-- Global private investment firm,Bridgewest Group,recognized for developing innovative companies in life sciences,software,and deep tech,is pleased to anno

02-13 Bridgewest Group

From O Levels to a Medicine, Dentistry or Law Degree in Just 9 Months

SINGAPORE,Feb. 11,2025-- With the growing demand for doctors,Singapore has increased the number of recognised foreign medical schools and ambitious students aiming for careers in medicine,dentistry or

02-13 East Asia Institute of Management (EAIM)

NEOM Investment Fund partners with Paradromics to drive innovation in neurotechnology healthcare

Strategic partnership with Paradromics will accelerate advancements in brain-computer interfaces and establish a Center of Excellence in NEOM.

02-13 Paradromics

Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC

HONG KONG,Feb. 13,2025--Akeso,Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in the Phase 3 randomized,double-blind,mult

02-13 Akeso, Inc.

WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year

Ranked among the top 1% of companies assessed in the pharmaceutical industry Recognized as a leader in Green CRDMO,driving innovation for a healthier future

02-11

Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met Endpoints

CBL-514,the world\'s first investigational drug for large-area localized fat reduction,has demonstrated significant efficacy in its second and the last Phase 2b study (CBL-0205) before Phase 3.

02-11

SunCar Technology Group Integrates DeepSeek AI, Revolutionizing Automotive Service Intelligence

NEW YORK,Feb. 10,2025-- SunCar Technology Group Inc. ("SunCar" or the "Company") (Nasdaq: SDA),an innovative leader in cloud-based B2B auto services and auto e-insurance in China,t

02-11

Permascand and Magneto Special Anodes merge to create a global leader in the advanced electrochemical sector - David Ekberg joins as CEO of the new company

LJUNGAVERK,Sweden,Feb. 10,2025-- Swedish-basedPermascand,owned by Altor,has merged with Magneto Special Anodes to form a global leader in catalytic coatings and electrodes for premium segment customer

02-11

ChipMOS REPORTS JANUARY 2025 REVENUE

HSINCHU,Feb. 10,2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS),an industry leading provider of

02-11 ChipMOS TECHNOLOGIES INC.